Form 4: Amarin Corp PLC Director DiPaolo Receives Stock Options and Restricted Stock Units

Mark DiPaolo, a director of Amarin Corp PLC, was granted stock options and restricted stock units (RSUs) following the company's annual general meeting.

Summary

• Mark DiPaolo, a director of Amarin Corp PLC, received stock options and restricted stock units (RSUs) on April 18, 2024.
• The stock options grant is for 179,795 ordinary shares with an exercise price of $0.87.
• These options vest over three years, with 33% vesting on the first anniversary and the remainder vesting in equal quarterly installments.
• DiPaolo also received 50,287 RSUs, which vest in three equal installments on April 18, 2025, April 18, 2026, and April 18, 2027.
• Each RSU represents a contingent right to receive one ordinary share or cash in lieu thereof at Amarin's discretion.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options and RSUs is a standard practice that aligns director interests with shareholders, but it doesn't necessarily indicate a significant positive or negative outlook for the company.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of shareholders.
• The vesting schedule encourages long-term commitment from the director.
• The use of both stock options and RSUs provides a balanced incentive structure.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the options and RSUs suggest an expectation of continued service from the director.

Industry Context

Granting stock options and RSUs to directors is a common practice in the pharmaceutical industry to incentivize performance and align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value.
• Employees: May boost morale knowing leadership is incentivized to improve company performance.

Key Dates